Markets
MA Stock Indexes
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
Delcath Systems, Inc. (NQ: DCTH)
0.4106 USD  -0.0144 (-3.39%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Delcath Systems, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Delcath Systems Announces Clinical and Regulatory Appointments
July 17, 2008
New Executives Add Experience With FDA Approvals Read More
from Marketwired News Releases
Delcath Systems' Targeted Drug Delivery System for Liver Cancer Treatment to Be Featured on FOX Business News
July 15, 2008
Program to Discuss Trend Towards Regionalized Treatment of Cancer Read More
from Marketwired News Releases
Delcath Expands Multi-Center Phase III Trial for Metastatic Melanoma
June 24, 2008
University of Texas Medical Branch Extends Geographic Penetration Read More
from Marketwired News Releases
Delcath Adds Atlantic Health to Phase III Trial for Metastatic Melanoma
June 19, 2008
Company Foresees Trial Completion in 2009 Read More
from Marketwired News Releases
Delcath Announces Expanded Clinical Initiatives at Annual Meeting Today
June 04, 2008
CEO Reviews Company's Progress, Goals and Milestones Read More
from Marketwired News Releases
Delcath Adds the Cancer Center of Albany Medical Center to Phase III Trial for Metastatic Melanoma
June 04, 2008
from Marketwired News Releases
Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Cancer Center
June 03, 2008
from PR Newswire
Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
May 20, 2008
from PR Newswire
Delcath To Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
May 13, 2008
from PR Newswire
Update: Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
April 25, 2008
from PR Newswire
Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
April 25, 2008
from PR Newswire
Delcath Systems Presents Positive Phase II Data on Delcath PHP System in Treatment of Inoperable Liver Metastases
March 31, 2008
Overall Survival of 40 Months Suggests Significant Benefit from Targeting Unresectable Liver Metastases Using PHP System Read More
from Business Wire News Releases
Law Firm Gersten Savage Exceeded $900 Million in 2007 Transactions
February 20, 2008
2007 PIPE Market League Tables rank Gersten Savage in top 12 issuer's counsel Read More
from PR Newswire
Delcath Systems to Host Conference Call to Provide Corporate Update
February 13, 2008
from Business Wire News Releases
Delcath and Aethlon Medical Sign Collaboration Agreement to Research and Develop Advanced Filtration Technology
January 30, 2008
from Business Wire News Releases
Delcath and Aethlon Medical Sign Collaboration Agreement to Research and Develop Advanced Filtration Technology
January 30, 2008
from Business Wire News Releases
Delcath System Gains Significant Exposure Through Presentations at Several Prominent Scientific Meetings
January 24, 2008
from Business Wire News Releases
Delcath Appoints Three Leading Physicians to Its Newly Formed Scientific Advisory Board
January 03, 2008
from Business Wire News Releases
Delcath Granted Japanese Patent for Delcath System
November 29, 2007
IP Portfolio Expanded and Updated To 28 Patents Read More
from Business Wire News Releases
Delcath Resumes Enrollment in Phase III and Phase II Trials
November 20, 2007
from Business Wire News Releases
Delcath Voluntarily Defers Accrual in Clinical Trials
October 23, 2007
Management to Host Conference Call Today at 10:00 a.m. Eastern Time Read More
from Business Wire News Releases
Sector Close Up: Pharmaceutical and Biotech Stocks -- Is Gene Therapy the Next Major Breakthrough in Cancer Treatment?
October 22, 2007
from Marketwired News Releases
Delcath Systems Technology Profiled in European Medical Technology Publication
October 18, 2007
from Business Wire News Releases
Delcath Treatment for Liver Cancer is ''Featured Clinical Trial'' in Latest National Cancer Institute (NCI) Cancer Bulletin
October 11, 2007
from Business Wire News Releases
Delcath Systems Issues CEO Letter to Shareholders
October 04, 2007
from Business Wire News Releases
Delcath Announces Closing of $14.2 Million Investment by Institutional Investors
September 26, 2007
Proceeds To Fund Completion of Phase III Trial for the Treatment of Liver Cancer. Read More
from Business Wire News Releases
Delcath to Present at the 12th Annual Drug Delivery Technologies & Deal Making Conference
September 24, 2007
from Business Wire News Releases
Delcath Systems, Inc. Raises $14.2 Million in Private Offering
September 18, 2007
Funding to Support Continued Development of Pipeline Read More
from Business Wire News Releases
Delcath to Present at the CL King Best Ideas Conference
September 18, 2007
from Business Wire News Releases
Delcath to Present at the ThinkEquity Partners' 5th Annual Growth Conference
September 17, 2007
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here